Mechanism of astragaloside IV enhancing the sensitivity of non-small cell lung cancer to bevacizumab via the lncRNA-PVT1/miR-361-3p/HMGB1 axis
AST-IV increased miR-361-3p expression while suppressing HMGB1 via downregulation of lncRNA-PVT1, thereby enhancing BV sensitivity in NSCLC.
Authors
- Fengxia Chen (ORCID: https://orcid.org/0009-0001-9187-0452)
- Mingfang Huang
- Liang Li (ORCID: https://orcid.org/0009-0006-7270-4105)
- Dewei Wang (ORCID: https://orcid.org/0000-0003-0823-2749)
Institutions
- Hainan General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Immunobiology
- Published
- 2025-09-08
- DOI
- https://doi.org/10.1016/j.imbio.2025.153115
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00